Philip Dunne
banner
drpipdunne.bsky.social
Philip Dunne
@drpipdunne.bsky.social
Phenotypic plasticity in colorectal cancer. Group leader at QUB Belfast and CRUK Scotland Institute.

CRUK-SI: https://tinyurl.com/5fr9n2ew
QUB: https://tinyurl.com/4b68vf56
Reposted by Philip Dunne
And the original publication is here:
Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes | EMBO reports share.google/JXMzGDRzpl0E...
Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes | EMBO reports
imageimageMetastatic primary tumours upregulate Upp1 in neutrophils, which elevates circulating uracil. UPP1-expressing neutrophils accumulate in the lung where they inhibit CD8+ T cells, promote fibronectin deposition and support metastatic niche ...
share.google
July 28, 2025 at 3:21 PM
Reposted by Philip Dunne
My lab at hiring! - we have TWO postdoc positions (one computational, one wet lab focussed) at Yale @yaleschoolofmed.bsky.social, working closely with our group members at University of Cambridge, UK @cambridgeuni.bsky.social

Please help to spread the word!

Adverts with full details below ⬇️
April 26, 2025 at 12:26 AM
Reposted by Philip Dunne
Members of IMPACT span wet-lab scientists, pathologists, bioinformaticians, patient involvement managers, image analysts, technicians, clinicians, students, project managers, and lecturers among others, to ensure a wide range of expertise and optimum resource management!
March 26, 2025 at 5:29 PM
Reposted by Philip Dunne
With 5 distinct research groups led by @joedwardswwcrc.bsky.social, Campbell Roxburgh, Nigel Jamieson, Colin Steele, and @mcsorleystephen.bsky.social, IMPACT provides a human tissue-based translational research infrastructure in Glasgow, in collaboration with @drpipdunne.bsky.social and Xiao Fu! 🤝
March 26, 2025 at 5:29 PM